Bioventus Inc. (BVS)
NASDAQ: BVS · Real-Time Price · USD
7.53
+0.22 (3.01%)
At close: Aug 13, 2025, 4:00 PM
7.35
-0.18 (-2.39%)
Pre-market: Aug 14, 2025, 8:40 AM EDT
Bioventus Employees
Bioventus had 930 employees as of December 31, 2024. The number of employees decreased by 40 or -4.12% compared to the previous year.
Employees
930
Change (1Y)
-40
Growth (1Y)
-4.12%
Revenue / Employee
$606,604
Profits / Employee
$1,991
Market Cap
503.70M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
BVS News
- 6 days ago - Bioventus to Present at the Canaccord Genuity 45th Annual Global Growth Conference - GlobeNewsWire
- 7 days ago - Bioventus Inc. (BVS) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 8 days ago - Bioventus Reports Second Quarter Financial Results - GlobeNewsWire
- 10 days ago - Bioventus Enters into a New $400 Million Senior Secured Credit Agreement Lowering Interest Expense and Providing Increased Liquidity - GlobeNewsWire
- 15 days ago - Bioventus Receives FDA 510(k) Clearances for two Next-Generation Peripheral Nerve Stimulation Products - GlobeNewsWire
- 15 days ago - Bioventus to Report Second Quarter of Fiscal Year 2025 Financial Results on August 6, 2025 - GlobeNewsWire
- 3 months ago - Bioventus Inc. (BVS) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Bioventus Reports First Quarter Financial Results - GlobeNewsWire